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Abstract
Background: Fasciola gigantica, the tropical liver fluke, infects buffaloes in Asian and African countries and causes
significant economic losses and poses public health threat in these countries. However, little is known of the
transcriptional response of buffaloes to infection with F. gigantica. The objective of the present study was to
perform the first transcriptomic analysis of buffalo liver infected by F. gigantica. Understanding the mechanisms that
underpin F. gigantica infection in buffaloes will contribute to our ability to control this parasite.
Methods: We challenged buffaloes with 500 viable F. gigantica metacercariae and collected liver samples through a
time course at 3, 42 and 70 days post-infection (dpi). Then, we performed gene expression analysis on liver samples
using RNA sequencing (RNA-Seq) Illumina technology and confirmed the RNA-Seq data by quantitative RT-PCR
analysis.
Results: Totals of 496, 880 and 441 differentially expressed transcripts were identified in the infected livers at 3, 42
and 70 dpi, respectively. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis
revealed that transcriptional changes in the liver of infected buffaloes evolve over the course of infection. The
predominant response of buffaloes to infection was mediated by certain pathways, such as MHC antigen
processing and presentation, Toll-like receptor 4 (TLR4), transforming growth factor beta (TGF-β), and the
cytochrome P450. Hepatic drug metabolizing enzymes and bile secretion were also affected.
Conclusions: Fasciola gigantica can induce statistically significant and biologically plausible differences in the
hepatic gene expression of infected buffaloes. These findings provide new insights into the response of buffaloes to F.
gigantica over the course of infection, which may be useful in determining pathways that can modulate host-parasite
interaction and thus potentially important for clearance of the parasite.
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Background
Fasciolosis is a serious liver disease caused by infection
with the digenetic trematodes Fasciola hepatica and F.
gigantica in temperate and tropical countries, respect-
ively [1]. These flukes enter the definitive host, such as
cattle, buffaloes, sheep and goats, orally and migrate to-
wards the liver via the peritoneal cavity. Clinically
affected animals exhibit a reduction in the growth rates,
development and productivity, and in severe cases fas-
ciolosis may lead to death [2]. Fasciolosis causes signifi-
cant economic losses in livestock industry [3] and is a
serious public health problem [4] by causing liver fibro-
sis, cirrhosis and cancer in humans [5]. Adult flukes
have been recovered from the bile duct of humans from
almost all continents [6, 7]. Reported estimates indicate
that up to 17 million people are infected worldwide and
that about 91 million are at risk [8].
Fasciola gigantica (tropical liver fluke), the major fluke
infecting ruminants in Asia and Africa, can adversely
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affect the weight gain, feed conversion efficiency and
reproduction of the affected buffaloes, imposing a ser-
ious threat to buffalo farming in these countries [9].
Current methods to control liver fluke infection rely on
the use of fasciocidal drugs. However, the escalating an-
thelmintic resistance (AR) in ruminants has become a
major concern [10, 11]. In an effort to discover novel al-
ternative fasciocidal drugs, the anthelmintic efficacy of
some medicinal plants against liver flukes have been
tested [12, 13]. Also, many immunization trials in mice
[14], rabbits [15], sheep [16, 17], goats [18] and cattle
[19] exploiting various antigens and adjuvant systems
[20] have been reported, but unfortunately these trials
did not evoke adequate immune response to protect
against challenge infection [18].
The liver fluke F. hepatica infection induces a domin-
ant Th2/T-regulatory type immune response [21] and is
known to modulate the host immune responses by vari-
ous mechanisms, including the production of immune-
suppressive cytokines and the alternative activation of
macrophages [22], the increase of regulatory T cells [23]
and the modulation of differentiation and function of
dendritic cells [24, 25]. In contrast, the immunity elicited
against F. gigantica infection is a mix of Th1/Th2 re-
sponse with a predominance of a Th2-biased pattern
[26, 27]. Recent studies have employed RNA sequencing
(RNA-seq) to elucidate the expressions of genes associ-
ated with host’s immune responses, metabolism and
transcriptomic changes in peripheral blood mononuclear
cells (PBMCs) [28–30]. However, much still is unknown
regarding the host immune response mechanisms
against F. gigantica and the extent to which this re-
sponse contributes to the resilience of buffaloes com-
pared to certain cattle breeds [31, 32].
Herein, we utilized RNA-Seq to determine the tran-
scriptional profiles of the liver of buffaloes infected with
F. gigantica. We compared the differential gene expres-
sion of liver from infected buffaloes to that from unin-
fected controls. As the first report of a transcriptome
analysis of buffalo liver during F. gigantica infection, the
data presented here provide new insights into the re-
sponse of buffalo to F. gigantica and revealed distinct
pathways that are dysregulated by F. gigantica in the
liver of infected buffaloes.
Methods
Metacercariae
Eggs of F. gigantica were collected from the gall-bladder
of naturally infected buffaloes from Guangxi Zhuang
Autonomous Region, PR China, and incubated at 29 °C
for 11 days. The newly-hatched miracidia were used to
infect Galba pervia snails (3–5 miracidia/snail) main-
tained in tissue culture plastic plate for 2 h and then in-
fected snails were incubated in order to allow the
miracidium stage to develop to sporocyst, redia, daugh-
ter redia and finally to cercariae. After 42 days, fully-
developed cercariae emerged from the snails and were
harvested and developed into metacercariae on 5 × 5 cm
cellophane sheets. The metacercariae on cellophane
sheets were washed several times with phosphate buff-
ered saline (PBS) and were used immediately to infect
buffaloes as described previously [33].
Animals and experimental infection
Eighteen buffaloes, 8–10-month-old, were purchased
from a water buffalo farm in Guangxi Zhuang Autono-
mous Region, PR China. Animals were randomly divided
into two groups: (i) nine for the non-infected control
group and (ii) nine for the infected group. Each group
was further subdivided into 3 subgroups, each of 3 buf-
faloes. To rule out any prior infection with F. gigantica,
faecal examination and ELISA testing using IgG and
IgM antibodies against F. gigantica were performed [34].
Also, after an acclimatization period of 2 weeks, all buf-
faloes were treated with triclabendazole 5% w/v oral sus-
pension in order to eliminate any liver flukes. After four
weeks of the withdrawal time, nine buffaloes were in-
fected orally with 500 viable metacercariae per animal,
whereas control animals were mock-inoculated with
0.85% NaCl solution without metacercariae [31]. At 3,
42 and 70 days post-infection (dpi), three animals from
each of the infected and control groups were sacrificed
and their livers were collected and stored at -80 °C until
analysis. Liver was selected because it is the target organ
and preferable habitat of F. gigantica flukes in the defini-
tive host (buffaloes) and in the mean time it performs
many vital physiological, metabolic and immunological
functions in the body [35]. At necropsy, whole blood
samples of all animals were collected aseptically into
tubes without anticoagulant and were separated by cen-
trifugation for collection and testing of the sera. Fasciola
gigantica infection was also confirmed by observing
gross pathological lesions associated with the presence
of adult flukes in the liver of infected animals.
RNA preparation
Total RNA was extracted from individual liver samples
using Trizol reagent according to the manufacturer’s in-
structions (Invitrogen Co. Ltd, San Diego, USA). All
RNA samples were treated with 20 units of RQ1 RNase-
Free DNase (Promega, Madison, USA) to remove any re-
sidual genomic DNA according to the manufacturer’s
protocol. Agilent Bioanalyzer 2100 (Agilent Technolo-
gies, CA, USA) and NanoPhotometer® spectrophotom-
eter (IMPLEN, Westlake Village, CA, USA) were used to
evaluate the integrity and purity of RNA samples,
respectively.
Zhang et al. Parasites & Vectors  (2017) 10:56 Page 2 of 13
Library preparation, clustering and transcriptome
sequencing
RNA (3 μg) of each liver sample was used for the prep-
aration of RNA libraries. Eighteen sequencing libraries
were constructed using NEBNext® Ultra™ RNA Library-
Prep Kit for Illumina® (NEB, Ipswich, MA, USA) follow-
ing the manufacturer’s protocol and index codes were
added to attribute the sequences to the corresponding
sample. Briefly, mRNA was purified from total RNA
using poly-T oligo-attached magnetic beads. Fragmenta-
tion was carried out using divalent cations under ele-
vated temperature in NEBNext First Strand Synthesis
Reaction Buffer (5×). First strand cDNA was synthesized
using random hexamer primer and M-MuLV Reverse
Transcriptase (RNase H-). Second strand cDNA synthe-
sis was subsequently performed using DNA Polymerase
I and RNase H. In order to select cDNA fragments ran-
ging from 150 bp to 200 bp, the library fragments were
purified with AMPure XP system (Beckman Coulter,
Beverly, USA). Three μl USER Enzyme (NEB, Ipswich,
MA, USA) were used with size-selected, adaptor-ligated
cDNA at 37 °C for 15 min followed by 5 min at 95 °C
before PCR. Then, the PCR was carried out with Phu-
sion High-Fidelity DNA polymerase, universal PCR
primers and index (X) Primer. PCR products were puri-
fied (AMPure XP system) and library quality was evalu-
ated on the Agilent Bioanalyzer 2100 system. The
clustering of the index-coded samples was performed on
a cBot Cluster Generation System using TruSeq PE
Cluster Kit v3-cBot-HS (Illumia) according to the manu-
facturer’s instructions.
Data analysis
Raw reads of fastq format were processed through in-
house Perl scripts. Clean reads were obtained by remov-
ing reads adapters, ploy-N containing reads and low
quality reads from raw data. At the same time, Q20,
Q30 and GC content of clean data were calculated. All
downstream analyses were based on the clean data with
high quality. Bubalus bubalis genome was used as the
reference genome and gene model annotation files were
downloaded from the water buffalo genome website
(http://www.ncbi.nlm.nih.gov/genome/?term=Bubalus
+bubalis). Index of the reference genome was built using
Bowtie v2.2.3 and paired-end clean reads were aligned to
Bubalus bubalis reference genome using TopHat
v2.0.12. We selected TopHat as the mapping tool be-
cause it can generate a database of splice junctions based
on the gene model annotation file and provide a better
mapping result than other non-splice mapping tools
[36]. HTSeq v0.6.1 was used to count the read’s numbers
mapped to each gene. Fragments Per Kilobase of tran-
script sequence per Millions base pairs sequenced
(FPKM) of each gene was calculated for estimating gene
expression levels. Differential expression analysis of two
groups (three replicates per group) was performed using
the DESeq R package (1.18.0) [37]. The resulting P-
values were adjusted using the Benjamini and Hoch-
berg’s approach for controlling the false discovery rate.
Gene expression differences were considered significant
if the adjusted P-value was < 0.05 and > 1.5-fold change
was observed in expression levels.
Gene ontology (GO) and Kyoto encyclopedia of genes
and genomes (KEGG) analysis
Gene Ontology (GO) enrichment analysis of differen-
tially expressed genes (DEGs) was implemented using
the GOseq R package [38]. GO enrichment analysis was
performed by collating all the GO terms that were sig-
nificantly enriched in the identified DEG, and followed
by filtering the DEGs based on the biological functions.
All DEGs were mapped to GO terms in the database
(http://www.geneontology.org/), and then gene numbers
were calculated for every term using the hypergeometric
test in order to obtain significantly enriched GO terms
for DEGs; these were compared to the genomic back-
ground. GO terms with corrected P-value less than 0.05
were considered significantly enriched by DEGs. KOBAS
software was used to perform pathway enrichment ana-
lysis and to test the statistical enrichment of the DEGs
in KEGG (http://www.genome.jp/kegg/) [39, 40]. This
analysis was used to identify significant enrichment of
genes involved in metabolic or signalling pathways. Ani-
malTFDB (http://www.bioguo.org/AnimalTFDB/) was
employed to identify and classify the transcriptional fac-
tors (TFs) in the genome of water buffalo.
qRT-PCR verification of RNA-Seq expression patterns
Total RNA was isolated from infected livers and non-
infection controls at 3, 42 and 70 dpi using RNeasy Mini
Kit (QIAGEN Gmbh, Hilden, Germany). DNase-digested
total RNA (1 μg) was reverse-transcripted to single
strand cDNA using the RT2 First Strand Kit (QIAGEN
Science, Maryland, USA) according to the manufactur-
er's protocol. RT2 SYBR® Green ROX qPCR Mastermix
(QIAGEN Gmbh, Hilden, Germany) was used to per-
form qRT-PCR reaction on ABI’s real-time PCR cycler,
the ABI 7500, according to the manufacturer’s instruc-
tions. Eleven genes were randomly selected for qRT-PCR
verification. Forward (F) and reverse (R) primer pairs
used to amplify genes of interest in the qRT-PCR reac-
tions are listed in Table 1. The amplification reactions
were performed using following conditions: 95 °C for
10 min, 40 cycles of 95 °C for 15 s, 60 °C for 1 min.
Melting curve analysis was carried out using following
conditions: 1 min at 95 °C, 65 °C for 2 min and progres-
sive increase from 65 °C to 95 °C to ensure that a single
product was amplified in each reaction.
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Results
Confirmation of F. gigantica infection in buffaloes
Fasciola gigantica infection was confirmed in all chal-
lenged buffaloes by observing gross pathological lesions
and adults F. gigantica flukes (Additional files 1 and 2:
Figure S1 and Figure S2). Livers of the control unin-
fected buffaloes appeared normal and were free of any F.
gigantica flukes. Serological testing using ELISA con-
firmed the infection in all animals challenged with meta-
cercariae at 42 and 70 dpi.
Transcriptomic features of buffalo livers following F.
gigantica infection
Over 58,000,000 raw reads (Additional file 3: Table
S1) were obtained from each liver sample. The RNA-
seq raw data are available at NCBI (accession no:
PRJNA341921). More than 53,000,000 clean reads
were obtained after removing low quality reads and
adaptors. More than 70% clean reads were distributed
in exon regions and the rest in introns or intergenics.
A total of 496, 880 and 441 transcripts were identi-
fied as differentially expressed at 3, 42 and 70 dpi,
respectively, compared to non-infected control groups
(Fig. 1). The RNA-seq results were confirmed by
qRT-PCR (Fig. 2). This analysis revealed five DEGs in
all animal groups including butyrophilin subfamily 1
member A1-like (Gene ID: 102404197), myeloid-
associated differentiation marker-like (Gene ID:
102406172), phosphoserine aminotransferase 1 (Gene
ID: 102410803), and two new genes (Fig. 3).
GO classification
GO enrichment analysis (www.geneontology.org) re-
vealed top 30 significant differentially expressed GO
terms that were classified into “molecular function”,
“biological process”, and “cellular component” as shown
in Fig. 4. At 3 dpi, several GO terms classified in bio-
logical process showed upregulation. Only two signifi-
cant GO terms were classified under “cellular
component”, including “extra chromosomal circular
DNA” and “extra chromosomal DNA”. While at 42 dpi,
top 30 significant differentially expressed GO terms were
only classified into “molecular function” and “biological
process”. The “immune response”, “immune system
Table 1 Primers used in the quantitative RT-PCR in the present study
Primer name Primer sequence (5' to 3') Length of qPCR products (bp)
CYTP450F AGCAGCAGACAACATCAACCA 122
CYTP450R CAATCGTCCTCTTCCCCATC
IL7RF CAGAGGAGAGTGAGAAGCAGAGG 275
IL7RR GGGTTGGAATGGAAATGGAG
NKRF GCAATGTCAGCAATCAAGTCAG 174
NKRR TCCTCTTCTTCCTCCACACACA
IL1R2F TGTGAGGGGAACTCGCTTACTC 105
IL1R2R GTGATGTTGTATTGCCTGCCTTT
BUT-LF AAGAGAGAGCTTGCCAGAAGGA 143
BUT-LR GATAAGACGAGGTTGGGGTGAG
IP6K3F CACGGCAGCAGTGTCTTCA 94
IP6K3R CATCGTAGGTGGTGTGTTCATTC
CD1EF TTCCAGCCAAATCACAGACAA 133
CD1ER TCACTTCCCCTCCACTTCTCC
CTSHF GCTTCAGTCACCCAACTCCAC 118
CTSHR ATACCAGCCAGCATCCCTACA
SOD3F GACTGCCTCCTCTCTGCCTTT 150
SOD3R TGTCCCCAGCAACTCTTTTC
NCF4F CTGTTTCCTCGCCTTGTTCC 273
NCF4R CCTCCCTTCACCGCTTACTTAC
βF GGACTTCGAGCAGGAGATGG 138
βR AGGAAGGAAGGCTGGAAGAGA
b561F GTATGTACCGAGGCGGCATT 148
b561R ACTTTGGTGGTGCGTTTGG
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Fig. 2 Verification of the gene expression by qRT-PCR. Eleven genes were selected randomly for validation of the RNA-seq data. Data of RNA-seq
verified by qRT-PCR at 3 (a), 42 (b) and 70 (c) days post-infection
Fig. 1 Volcano map of the differentially expressed genes between infected and control buffaloes. Significantly differentially expressed genes are
shown as red (up) or green (down) dots. No significant difference between the expressions of genes is indicated by blue dots. Ordinate represents
the magnitude of gene expression changes. The x-axis represents the value of log2(fold change) and the y-axis shows the value of -log10(pval). a,
b and c represent differentially expressed genes at 3, 42 and 70 days post-infection, respectively
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process” and “cytokine activity” were significantly
enriched at 70 dpi.
KEGG analysis
KEGG database was used to identify alterations in the
biological pathways during F. gigantica infection. A total
of 501 transcripts were assigned to 183 KEGG pathways
at 3 dpi. At 42 dpi 1,194 transcripts were assigned to 229
KEGG pathways, whereas at 70 dpi 639 transcripts were
assigned to 193 KEGG pathways. Top 20 most highly rep-
resented pathways in each group are shown in Fig. 5.
Transcription factors
AnimalTFDB (http://www.bioguo.org/AnimalTFDB/)
was used to identify and classify transcription factors in
the buffalo genome. As shown in Fig. 6, there are signifi-
cant differences among the animal groups. Eighty-two
differentially expressed transcription factors were identi-
fied in infected livers. For example, Smad 6, which in-
hibits the transforming growth factor beta (TGF-β)
signaling pathway, was upregulated at 3 dpi. Also, B cell
lymphoma 6 (Bcl6) was downregulated at 3 dpi, but was
upregulated at 42 dpi. The differentially expressed tran-
scription factors were classed into 5 clusters according
to their expression patterns: (i) four highly expressed
genes at 3 dpi; (ii) 19 highly expressed genes at 42 and
72 dpi; (iii) 43 highly expressed genes at 42 dpi; (iv) 2
highly expressed genes in all groups; and (v) 33 genes
clustered into other clusters.
Discussion
In the present study, we employed RNA-Seq Illumina
technology to uncover the hepatic transcriptomic
changes of buffaloes infected with F. gigantica. Specific-
ally, we compared the gene expression patterns of the
liver of infected and uninfected buffaloes. GO and
KEGG enrichment analyses revealed that experimental
infection with F. gigantica can influence the expression
of genes associated with the host immune response and
metabolism. Notably, regulation of some genes indicated
potential parasite manipulation to facilitate infection;
these included the major histocompatibility complex
(MHC) class II (MHC-II) related genes that were re-
pressed, the acute phase protein LBP which was down-
regulated, modulation of the expression of the
transcriptional repressor Bcl6 over the course of infec-
tion, upregulation of the transcription factor Smad6, re-
pression of genes involved in the oxidative burst, and
finally, modulation of the regenerative response related
genes (Brca1 and Blm). The expression patterns of these
genes through a time course of 3, 42 and 70 dpi and
their relevance to the pathogenesis of F. gigantica infec-
tion in buffaloes are discussed in the following sections.
Immune responses
Fasciola hepatica infection in lambs can induce a dom-
inant Th2-biased immune response along with suppres-
sion of Th1/Th17 responses [21] and can negatively
impact Th1 responses to bystander infections, such as
during coinfection with Mycobacterium tuberculosis
[41]. Buffaloes, on the other hand, can exhibit a combin-
ation of Th1 and Th2 cytokine expression pattern in re-
sponse to F. gigantica infection [42, 43] or post
vaccination with the recombinant fatty acid binding pro-
tein (rFABP) and glutathione S-transferase (rGST) pro-
tein [44]. Therefore, it is reasonable to expect some
differences in the expression patterns of immune re-
sponse genes that interact with or are stimulated in re-
sponse to infection with F. gigantica and F. hepatica.
Innate immunity is the first line of defense against
Fasciola and in the mean time it plays key roles in prim-
ing the adaptive immune response [45]. In mammals,
antigen processing and presentation are essential for
triggering the downstream cellular and/or humoral im-
mune responses [46]. The KEGG results revealed that
genes involved in the (MHC-II) pathway were downreg-
ulated at 3 dpi, in agreement with others [23], and that
genes involved in the MHC-I pathway were upregulated
at 42 dpi. Interestingly, at 70 dpi we did not observe any
significant alteration in the regulation of MHC-I or
MHC-II, suggesting that F. gigantica is capable of evad-
ing the host immune system. This unique pattern should
be further investigated.
Fig. 3 Venn diagram showing the overlap of the differentially
expressed genes between Fasciola gigantica-infected liver sample
groups at 3 (a), 42 (b) and 70 (c) days post-infection. Transcripts that
are common to multiple time points are shown by the overlap
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The suppression of the MHC-II related genes during
early F. gigantica infection might correlate with a com-
promised ability of the MHC class II molecules to
present processed F. gigantica antigens to CD4(+) T-
lymphocytes. Because the stimulation, differentiation,
and function of CD4 T cells is central to the
Fig. 4 Differentially expressed GO terms. Differentially expressed genes (DEGs) were classified into three main categories: molecular function,
cellular component and biological process. The identified functions and the corresponding numbers of DEGs for each GO category are shown. a
Top 30 DE molecular function, cellular component and biological process in A2T (infected) vs A2C (control) at 3 dpi. b Top 30 DE molecular
function and biological process in A5T (infected) vs A5C (control) at 42 dpi. c Top 30 DE molecular function, cellular component and biological
process in A6T (infected) vs A6C (control) at 70 dpi
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development of type I immune responses, any reduction
in the interaction between MHC class II molecules and
the T cell receptor (TCR) might affect the Th1/Th2 bal-
ance, similar to what has been reported in F. hepatica
infection [21]. A recent study demonstrated that glyco-
conjugates from F. hepatica can induce high levels of IL-
10 and IL-4, supporting the role of glycans in the
polarization of host immune response toward a Th2/
regulatory response via induction of IL-10 [25]. Whether
the glycosylated molecules of F. gigantica could have
the same immune-modulatory effect remains to be
investigated.
Lipoppolysaccharide binding protein (LBP), acute
phase protein, is produced mainly by hepatocytes [47]
and plays an important role in lipopolysaccharide (LPS)
signaling and innate immunity [48]. LBP can activate
Toll-like receptor 4 (TLR4), which mediates the expres-
sion of pro-inflammatory cytokines and other immune
response related genes [49]. In our study, the downregu-
lation of LBP at 3 dpi, probably mediated by the parasite
fatty acid binding protein [49], suggests that host pro-
inflammatory responses may be suppressed during early
F. gigantica infection. This result supports previous find-
ings that showed that F. hepatica infection and antigens
can suppress Th1 immune responses in vivo [41, 50].
Hence, the reduced hepatic production of the LBP and
the subsequent suppression of the pro-inflammatory cy-
tokines might be recognized as mechanistically import-
ant for survival of the liver flukes in a hostile host
environment. Suppression of inflammation has been
Fig. 5 Statistics of KEGG pathway enrichment. The x-axis shows the enrichment factor; the y-axis corresponds to KEGG Pathway. The color of the
dot represents q value and size of the dot represents the number of DEGs mapped to the reference pathways. a, b and c represent the top 20
statistics of KEGG pathway enrichment for DEGs observed at 3, 42 and 70 dpi, respectively
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reported in sheep liver infected with F. hepatica [28]. In-
deed, the importance of mounting strong Th1 immune
responses in the protection of the host against challenge
infection has been previously demonstrated in vaccin-
ation trials in livestock [51]. While the current literature
focussed more on the host immune responses to
Fasciola has focused on inflammatory responses, our
finding suggests that genes that help to keep inflamma-
tion in check may also be important in the host
response.
Intercellular adhesion molecule-1 (ICAM-1), a mem-
ber of the immunoglobulin superfamily, is an endothe-
lial- and leukocyte-associated transmembrane protein.
ICAM-1 facilitates recruitment of circulating leukocyte
(including lymphocytes) to infection/inflamed sites and
mediates the interaction between T cells and their target
cells [52]. The increase of ICAM-1 expression at 3 dpi is
probably beneficial for the adhesion of lymphocytes to
the endothelial cells and their migration into the liver,
which is a prerequisite of attack of target cells by cyto-
toxic T lymphocytes. Interestingly, IL-1β was found up-
regulated at 70 dpi. IL-1β regulates a number of pro-
inflammatory genes such as IL-8, a chemokine that at-
tracts neutrophils, and eosinophils, and is involved in
antibody-dependent cell-mediated cytotoxicity (ADCC)
pathway [53–55], which has a major importance in the
defense against Fasciola [26]. At 42 dpi, Itgam, which in-
hibits Ncf1 and Ncf4, leading to impairment of oxidative
burst, was significantly upregulated. This suggests that F.
gigantica alters the expression of genes involved in the
oxidative burst process in order to avoid killing by nitric
oxide (NO), which is considered as a defense mechanism
against infection [56]. This finding is consistent with the
previous result that NO production and nitric oxide syn-
thase 2 (NOS2) expression are downregulated when
monocyte-derived macrophages of human origin were
exposed to F. hepatica fatty acid binding protein, known
as Fh12 [57]. Our observation is also in agreement with
Fig. 6 Heatmap of the differentially expressed (DE) transcription factors. a, b and c are differentially expressed transcription factors at 3, 42 and 70
dpi, respectively. The red (up) and green (down) dots represent the significantly differential expressed transcripts; the black represents the
transcripts whose expression levels did not reach statistical significance
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previous studies that reported inability of ovine macro-
phages to generate NO when incubated with newly
excysted juveniles of F. hepatica in vitro [58] and the
significant downregulation of NOS2 gene, encoding in-
ducible nitric oxide synthase (iNOS), which converts ar-
ginine into citrulline and NO during the acute and
chronic stages of ovine F. hepatica infection [21].
We also identified DEGs involved in processes associ-
ated with the regulation of Th2 cell differentiation and
B-cell activation. We also found, at 3 dpi, upregulation
of immunoglobulin variable gene (Ighv1s28, Ig heavy
chain Mem5), which inhibits Pro-B cell differentiation to
Pre-B1 cell. At 42 dpi, Cd3e, Zap70 and Il-17r genes,
which are involved in inhibiting the hematopoietic stem
cell (HSC) differentiation, were upregulated. Our study
also identified DE transcription factors, such as the tran-
scriptional repressor Bcl6, which is essential for the for-
mation of T-follicular helper (Tfh) cells [59–61], which
facilitates T cell-dependent B cell differentiation and
antibody responses [62]. Bcl6 was downregulated at 3
dpi, but was upregulated in 42 dpi, suggesting that F.
gigantica infection can modulate Bcl6 expression (a trad-
itional regulator of a Th2 response) over the course of
infection. This finding is also in agreement with previous
work [28] and is consistent with the literature where
changing from Th1 to Th2 response occurs as infection
establishes, correlating with the development of adaptive
B cell response and the generation of Fasciola-specific
antibodies within 4 weeks of infection [45]. The tran-
scription factor Smad6 is an inhibitor of TGF-β signaling
pathway [63], which plays a key role in fibrosis during F.
hepatica infection [64] and can suppress the growth and
self-renewal of hepatic progenitor cells [65]. In our
study, Smad6 was found upregulated at 3 dpi, suggesting
that Smad6 may play a role in controlling fibrosis during
the early stage of F. gigantica infection. A previous study
reported a similar finding in PBMC isolated from sheep
infected with F. hepatica where the expression level of
the inhibitory-Smad protein, Smad7, was upregulated,
which has been hypothesized to play a role in limiting
the fibrosis formation during acute and chronic stage of
infection [21].
In contrast, increased levels of PBMC-derived TGF-β1
have been observed in early phases of the infection with
F. hepatica in cattle [22]. These findings indicate that
molecules of the TGF-β-pathway can potentially exacer-
bate and ameliorate the liver fibrotic process depending
on the stage of the infection, host species and Fasciola
species causing the infection.
Metabolic dysregulation
Liver is a very important metabolic and drug clearance
organ because changes in the activities or regulation of
hepatic drug metabolizing enzymes can alter clearance
of chemical compounds. Previous reports indicated that
F. hepatica infection can induce alterations in the mito-
chondrial electron transport chain and the enzymes that
are responsible for drug metabolism in the liver [28, 66,
67]. Several hepatic enzymes known to play key roles in
the mammalian metabolic and clearance processes, in-
cluding Flavin monooxygenase (FMO), carboxylesterases
(CES), members of cytochrome P450 enzyme, aldehyde
dehydrogenase (ALDH), glutathione S- transferase
(GST), and paraoxonase (PON), were found to be af-
fected by F. gigantica infection in our study. For ex-
ample, the expression level of Pon1 in infected liver was
2.2-fold higher compared to the control liver at 3 dpi. At
42 and 70 dpi, infected buffaloes had lower levels of
Pon3 (58%) and Ces2 (49%), respectively. At 3 dpi, the
mRNA level of Aldh1a1 was 1.6-fold higher than the
corresponding control. Other aldehyde dehydrogenases
in the infected liver had lower levels [e.g. Aldh3a2 (43%),
Aldh1l1 (51%), Aldh4a1 (57%) at 42 dpi and Aldh1l1
(50%) at 70 dpi]. Also, Fmo3 and Fmo5 showed de-
creased levels (60%) in infected liver samples. The
mRNA levels of GST decreased in infected livers at 42
dpi [e.g. Gsta2 (50%) and MGst1 (58%)] and at 70 dpi
[e.g. Gsta1 (68%)].
Cytochrome P450 is a very important drug metabolizing
enzyme. KEGG analysis revealed that in the cytochrome
P450 pathway there are 2 upregulated transcripts (Gstm1
and Gsta3) at 3 dpi, 13 downregulated transcripts (Fmo3,
Fmo5, UDP-glucuronosyltransferase 2b4, UDP glucurono-
syltransferase 2 family, UDP-glucuronosyltransferase 2C1,
Ugt1a6, Ugt2b17, Ugt1a1, Adh5, Gsta2, Gsto1, Mgst1,
Maob) at 42 dpi and 4 downregulated transcripts (Ugt2a1,
Mgst1, Gsta5, Gsta3) at 70 dpi. The downregulation of
cytochrome P450 genes is consistent with previous results
[68]. The alterations of these enzymes suggest that infec-
tion of buffaloes with F. gigantica infection can modulate
drug pharmacokinetics, and this can vary over the course
of infection.
Genomic responses
The breast cancer 1 early onset (Brca1), which is a
tumor suppressor involved in cellular functions related
to cell replication and DNA synthesis was found down-
regulated at 3 and 42 dpi. Blm, coding blooms syndrome
helicase which is a member of the RecQ family of super-
family 2 helicases and plays critical role in the mainten-
ance of genome stability, was found upregulated at 42
dpi. The clinical relevance of the downregulation of
Brca1 or upregulation of Blm is still unknown, but it is
likely that Bcra1-mediated cell proliferation and Blm-
mediated genome integrity play a role in the regenerative
response of the liver to heal the damaged tissue caused
by F. gigantica infection. A similar observation was re-
ported in sheep livers infected with F. hepatica where
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genes associated with host cell cycle and mitosis were
found significantly upregulated [28].
Bile secretion
Because they live and induce pathological lesions in the
bile duct, F. gigantica flukes are expected to interfere with
bile synthesis and secretion. Indeed, alteration in the bile
production has been reported in F. hepatica infected
sheep [69]. The downregulation of the Na+ and D-glucose
transfer (Sglt1) gene, expressed at the cholangiocyte apical
plasma membrane, at 3 dpi can decrease the apical uptake
of glucose from the bile and this could affect the biliary
osmolarity. Genes related to the synthesis of carbonic acid
(H2CO3) from CO2 and H2O, which facilitates the excre-
tion of bile acid and glutathione (GSH) through kidney
were upregulated, potentially causing a reduction in the
amount of bile in the biliary duct.
Conclusions
Using RNA sequencing technology, we characterized
transcriptome profiles of water buffalo liver during ex-
perimental F. gigantica infection. Comparing the infec-
tion groups to the mock groups, 496, 880 and 441
significantly DEGs were identified at 3, 42 and 70 dpi,
respectively. Infected liver showed alterations in the ex-
pression of genes involved in immune responses, hepatic
drug metabolism, regenerative response, and bile secre-
tion. Several pathways, such as the MHC antigen pro-
cessing and presentation, TLR4 signalling, TGF-β
signalling, and cytochrome P450 pathway, have been al-
tered by F. gigantica infection. These findings suggest
that F. gigantica can modulate host immunity and in-
flammatory pathways in order to facilitate its survival
within the host. A better understanding of the immuno-
pathological mechanisms of F. gigantica infection may
provide new preventive and therapeutic strategies for
the control of fasciolosis in buffaloes.
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